hrp0098p3-309 | Late Breaking | ESPE2024

Metreleptin dramatically improves the metabolic pattern in a patient with mandibuloacral dysplasia progeroid syndrome (MADaM).

Filomena Madeo Simona , Rita Di Biase Anna , Grippa Mina , Trevisani Viola , Lucaccioni Laura , Calabrese Olga , Iughetti Lorenzo

Background: MADaM syndrome associated with MTX2 gene, is a very rare premature-aging syndrome, caused by a homozygous mutation in the MTX2 gene, which encodes for metaxin-2, a mitochondrial outer membrane protein involved in protein translocation into mitochondria and in TNF-a- induced apoptosis.Case report: Term male newborn, due to a physiological pregnancy [birth weight 4230 g (1.61 SD), length 56 cm (3.24 SD), head c...